Post-pandemic, the demand for better healthcare is driving Southeast Asia’s U$100 billion healthtech scene

18 July 2022

Before COVID-19, Southeast Asia’s healthcare ecosystem was already ballooning thanks to three key trends: a large middle income consumer class, demand for better healthcare, and higher longevity rates.

UOB expects 65% of Southeast Asia’s population to be middle class – defined by daily expenditure of US$10 to US$100 – by 2030, with 60% under 35 years of age.

With non-emergent procedures being delayed throughout the two-year pandemic, there has been increased acceptance of healthtech measures, from telemedicine, employee wellbeing and even genetics and diagnostic health.

As a result, the healthtech scene in the region, which was valued at US$37 billion in 2020, is set to hit the US$100 billion mark by 2025.

Malaysia’s long-term leadership in healthcare travel as well as its robust public and private healthcare systems have helped it constantly rank first in the world as a retirement living destination.

Today, Greater KL is home to a strong ecosystem of healthtech startups, which are leveraging the city’s top-notch health facilities while bringing Malaysian healthcare expertise to the wider Southeast Asian and Asia Pacific region.

Let us facilitate your growth in the region.


Reach out to our team


Receive updates from us

Generic Popup